Self-funded Administrative Services Only (ASO Prior Authorization/ Notification)
Customize your policy alerts
Sign up for all Baylor Scott & White Health Plan policy alerts
Know when Baylor Scott & White Health Plan releases new policies or updates existing guidance.
Monitor payer policy activity
Lists prior authorization and notification requirements and code listings for Baylor Scott & White Health Plan acting as third‑party administrator for self‑funded (ASO) employer plans; describes provider portal submission and verification responsibilities for providers and members in Texas.
No material clinical or coverage changes in this revision.
Prior Authorization / Notification Coverage Criteria
Prior Authorization and Notification Criteria (partial)
Prior authorization is required for services on the plan's prior authorization list; verify member benefits and eligibility before providing services. Notification is requested for certain services to support discharge planning and care coordination.
Partial code list (informational)
Partial listing of CPT, HCPCS, T- and U-codes included for ASO prior authorization/notification processing. This excerpt is informational and does not contain decision logic.
Examples of CPT/HCPCS codes referenced
Imaging and therapeutic radiology examples
- Head/neck CT/MR and CTA series (examples): 70481–70498, 70540–70549.
- Therapeutic radiology and brachytherapy planning/delivery (examples): 77262–77299, 77300–77338, 77372–77425.
Interventional, vascular and endovenous examples
Nuclear medicine, PET and cardiac imaging examples
- Nuclear/PET cardiac imaging (examples): 78430–78496, 78499, 78579–78582.
- PET whole-body/limited area examples: 78811–78813.
Procedure code listings (partial)
Selected procedural CPT codes from the ASO listing (partial). No clinical coverage criteria included in these excerpts.
Knee arthroscopy / related procedures
- Extended arthroscopy series: 29874–29889 (meniscectomy, synovectomy, debridement, ligament procedures, repair/reconstruction).
Code listing — partial
Additional CPT and unlisted procedure mappings used by ASO prior authorization/notification workflows; entries often include effective-date annotations for ASO processing.
Transplant and unlisted procedure mappings
Procedural code listing (no criteria in excerpt)
Procedural CPT codes subject to ASO prior authorization/notification (excerpt).
Selected device and spinal implant codes
Imaging code reference set
Imaging CPT codes and CTA/MR crosswalks included for authorization processing; many entries include effective/mapping dates.
Code inclusion list (part 7)
ASO code inclusion list (part 7) — therapeutic radiology, brachytherapy, radiation delivery and related device codes are listed with effective dates for authorization workflows.
Therapeutic radiology planning and simulation
Brachytherapy and physics codes
- Brachytherapy planning and special dosimetry examples: 77316–77321, 77331–77338, 77370.
Code content requirements and effective dates (partial)
Molecular pathology and genomic panel code content requirements: some CPT Level 8/9 entries specify required gene lists or minimum gene counts for panel validity.
Panel content requirements
- 81410 (aortic dysfunction/dilation panel) must include sequencing of at least 9 genes including FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, and MYLK.
- 81412 (Ashkenazi-associated disorders) must include sequencing of at least 9 specified genes (ASPA, BLM, CFTR, FANCC, GBA, HEXA, IKBKAP, MCOLN1, SMPD1).
- 81413 (cardiac ion channelopathies) must include sequencing of at least 10 genes including ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A.
- 81430 (hearing loss panel) must include sequencing of at least 60 genes (examples listed in descriptor).
- 81418 (pharmacogenomics panel) must include testing of at least 6 genes including CYP2C19 and CYP2D6 plus CYP2D6 duplication/deletion analysis.
Code listing (informational for authorization processing)
Informational listing of additional molecular/genomic and algorithmic assay codes used for authorization; entries include descriptors and effective dates but no standalone clinical decision criteria in this excerpt.
Selected genomic and algorithmic assay codes
Code listing (informational)
Selected unlisted (0001U etc.), proprietary (U-/T-) and clinical assessment procedure codes included for ASO authorization reference (informational).
Selected proprietary and U/T codes
- Neurophysiology and psychological testing examples: 95905 (motor/sensory nerve conduction), 95940–95941 (intraoperative monitoring), 96130–96139 (psychological testing services).
Code listing (no coverage criteria in excerpt)
Granular listings of temporary/proprietary (U/T) codes and advanced diagnostic/genomic tests used in ASO prior authorization/notification processing (partial).
Selected U/T code examples (part 12–13)
- 0265U–0268U examples (genomic and transcriptome testing) with effective dates (eg, 0265U effective 1/1/2022).
- 0349U–0351U series (radiostereometric analysis and associated genomic/protein algorithm tests) effective 1/1/2023.
Code listing (no standalone coverage criteria in excerpt)
Category III (T) codes and selected advanced procedural/technology codes included for provider reference in ASO prior authorization/notification workflows.
Category III and recent T-code batches
- Sample Category III codes and device/technology entries: 0350T–0352T, 0469T, 0479T–0484T, 0524T–0530T.
Code Tables and Effective Dates
| 22515 | Percutaneous vertebral augmentation (eg, kyphoplasty), 1 vertebral body; includes imaging guidance; additional vertebral bodies listed separately |
| 22526 | Percutaneous intradiscal electrothermal annuloplasty; single level |
| 22527 | Percutaneous intradiscal electrothermal annuloplasty; additional levels |
| 22532 | Arthrodesis, lateral extracavitary technique; thoracic |
| 22533 | Arthrodesis, lateral extracavitary technique; lumbar |
| 27125 | Hemiarthroplasty, hip, partial (mapped in excerpt alongside sacroiliac injection text) |
| 27130 | Total hip arthroplasty (mapped in excerpt alongside sacroiliac injection text) |
| 27403 | Arthrotomy with meniscus repair, knee |
| 27486 | Arthroplasty, knee, condyle and plateau; medial AND lateral compartments (total knee arthroplasty) - mapped to revision codes |
| 29805 | Arthroscopy, shoulder, diagnostic, with or without synovial biopsy |
| 29822 | Arthroscopy, shoulder, surgical; debridement, limited |
| 29827 | Arthroscopy, shoulder, surgical; with rotator cuff repair |
| 29860 | Arthroscopy, hip, diagnostic with or without synovial biopsy |
| 29866 | Arthroscopy, knee, surgical; osteochondral autograft(s) (eg, mosaicplasty) |
| 44135 | Unlisted procedure, stomach = Intestinal allotransplantation; from cadaver donor. |
| 44705 | Unlisted procedure, stomach = Preparation of fecal microbiota for instillation, including assessment of donor specimen. |
| 47135 | Unlisted procedure, stomach = Liver allotransplantation, orthotopic, partial or whole, from cadaver or living donor, any age. |
| 62263 | Percutaneous lysis of epidural adhesions using solution injection or mechanical means; multiple adhesiolysis sessions; 2 or more days. |
| 62264 | Percutaneous lysis of epidural adhesions ... 1 day. |
| 62321 | Injection(s) including imaging guidance; interlaminar epidural or subarachnoid, cervical or thoracic. |
| 62350 | Implantation, revision or repositioning of tunneled intrathecal or epidural catheter; without laminectomy |
| 62351 | Implantation, revision or repositioning of tunneled intrathecal or epidural catheter; with laminectomy |
| 62360 | Implantation or replacement of device for intrathecal or epidural drug infusion; subcutaneous reservoir |
| 62361 | Implantation or replacement of device for intrathecal or epidural drug infusion; nonprogrammable pump |
| 62362 | Implantation or replacement of device for intrathecal or epidural drug infusion; programmable pump |
| 63001 | Laminectomy with exploration and/or decompression; cervical |
| 63003 | Laminectomy with exploration and/or decompression; thoracic |
| 63005 | Laminectomy with exploration and/or decompression; lumbar |
| 64454 | Injection(s), anesthetic agent(s) and/or steroid; genicular nerve branches, including imaging guidance |
| 64479 | Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural with imaging guidance, cervical or thoracic |
| 70481-70555 (selected) | CT and MRI head/orbit/neck series with contrast and non-contrast variations |
| 75571-75577 | Cardiac CT/MRI and CTA codes including coronary evaluation and postprocessing |
| 77262 | Therapeutic radiology treatment planning; intermediate (listed with 10/1/2021 date) |
| 77263 | Therapeutic radiology treatment planning; complex (listed with 10/1/2021 date) |
| 77280 | Therapeutic radiology simulation-aided field setting; simple (10/1/2021) |
| 77285 | Therapeutic radiology simulation-aided field setting; intermediate (10/1/2021) |
| 77290 | Therapeutic radiology simulation-aided field setting; complex (10/1/2021) |
| 77293 | Respiratory motion management simulation (List separately) (10/1/2021) |
| 77295 | 3-dimensional radiotherapy plan, including dose-volume histograms (10/1/2021) |
| 77299 | Unlisted procedure, therapeutic radiology clinical treatment planning (10/1/2021) |
| 77300 | Basic radiation dosimetry calculation (10/1/2021) |
| 77301 | Intensity modulated radiotherapy plan (10/1/2021) |
| 77316 | Brachytherapy isodose plan; simple (10/1/2021) |
| 77317 | Brachytherapy isodose plan; intermediate (10/1/2021) |
| 77318 | Brachytherapy isodose plan; complex (10/1/2021) |
| 77321 | Special teletherapy port plan (10/1/2021) |
| 77331 | Special dosimetry (10/1/2021) |
| 77332 | Treatment devices, design and construction; simple (10/1/2021) |
| 77333 | Treatment devices, design and construction; intermediate (10/1/2021) |
| 77334 | Treatment devices, design and construction; complex (10/1/2021) |
| 77336 | Continuing medical physics consultation, per week of therapy (10/1/2021) |
| 77338 | Multi-leaf collimator device(s) for IMRT, per IMRT plan (10/1/2021) |
| 77372 | Radiation treatment delivery, stereotactic radiosurgery (SRS), complete course, cranial lesion(s), 1 session (10/1/2021) |
| 77373 | Stereotactic body radiation therapy, treatment delivery, per fraction (course not to exceed 5 fractions) (10/1/2021) |
| 77387 | Guidance for localization of target volume, includes intrafraction tracking (10/1/2021) |
| 77399 | Unlisted procedure, medical radiation physics, dosimetry and special services (10/1/2021) |
| 77402 | Radiation treatment delivery; Level 1, includes imaging guidance when performed (10/1/2021) |
| 77407 | Radiation treatment delivery; Level 2, single-isocenter including imaging guidance when performed (10/1/2021) |
| 77412 | Radiation treatment delivery; Level 3, multiple isocenters or single-isocenter with active motion management (10/1/2021) |
| 77417 | Therapeutic radiology port image(s) (10/1/2021) |
| 77423 | High energy neutron radiation treatment delivery (10/1/2021) |
| 77424 | Intraoperative radiation treatment delivery, x-ray, single session (10/1/2021) |
| 77427 | Radiation treatment management, 5 treatments (10/1/2021) |
| 77431 | Radiation therapy management with complete course of therapy consisting of 1 or 2 fractions (10/1/2021) |
| 77432 | Stereotactic radiation treatment management of cranial lesion(s), 1 session (10/1/2021) |
| 77435 | Stereotactic body radiation therapy, treatment management, per treatment course (not to exceed 5 fractions) (10/1/2021) |
| 77469 | Intraoperative radiation treatment management (10/1/2021) |
| 77470 | Special treatment procedure (eg total body irradiation) (10/1/2021) |
| 77499 | Unlisted procedure, therapeutic radiology treatment management (10/1/2021) |
| 77520 | Proton treatment delivery; simple, without compensation (effective 9/1/2021) |
| 77522 | Proton treatment delivery; simple, with compensation (9/1/2021) |
| 77523 | Proton treatment delivery; intermediate (9/1/2021) |
| 77600 | Hyperthermia, externally generated; superficial (10/1/2021) |
| 77605 | Hyperthermia, externally generated; deep (10/1/2021) |
| 77610 | Hyperthermia generated by interstitial probe(s); 5 or fewer applicators (10/1/2021) |
| 77615 | Hyperthermia by interstitial probes; more than 5 applicators (10/1/2021) |
| 77620 | Hyperthermia generated by intracavitary probe(s) (10/1/2021) |
| 77750 | Infusion or instillation of radioelement solution (includes 3-month follow-up care) (10/1/2021) |
| 77761 | Intracavitary radiation source application; simple (10/1/2021) |
| 77762 | Intracavitary radiation source application; intermediate (10/1/2021) |
| 77763 | Intracavitary radiation source application; complex (10/1/2021) |
| 77767 | Remote afterloading HDR radionuclide skin surface brachytherapy; lesion diameter up to 2.0 cm or 1 channel (10/1/2021) |
| 77768 | Remote afterloading HDR radionuclide skin surface brachytherapy; lesion >2.0 cm or multiple channels (10/1/2021) |
| 77770 | Remote afterloading HDR radionuclide interstitial or intracavitary brachytherapy; 1 channel (10/1/2021) |
| 77771 | Remote afterloading HDR radionuclide interstitial or intracavitary brachytherapy; 2-12 channels (10/1/2021) |
| 77772 | Remote afterloading HDR radionuclide interstitial or intracavitary brachytherapy; over 12 channels (10/1/2021) |
| 77778 | Interstitial radiation source application, complex (10/1/2021) |
| 77789 | Surface application of low dose rate radionuclide source (10/1/2021) |
| 77790 | Supervision, handling, loading of radiation source (10/1/2021) |
| 77799 | Unlisted procedure, clinical brachytherapy (10/1/2021) |
| 78012 | Thyroid uptake, single or multiple quantitative measurements (8/1/2018) |
| 78013 | Thyroid imaging (including vascular flow) (8/1/2018) |
| 78014 | Thyroid imaging with uptake measurements (8/1/2018) |
| 78015 | Thyroid carcinoma metastases imaging; limited area (eg neck and chest only) (8/1/2018) |
| 78016 | Thyroid carcinoma metastases imaging; with additional studies (8/1/2018) |
| 78018 | Thyroid carcinoma metastases imaging; whole body (8/1/2018) |
| 78020 | Thyroid carcinoma metastases uptake (List separately) (8/1/2018) |
| 78070 | Parathyroid planar imaging (including subtraction) (8/1/2018) |
| 78071 | Parathyroid planar imaging with tomographic (SPECT) (8/1/2018) |
| 78072 | Parathyroid SPECT with concurrently acquired CT for localization (8/1/2018) |
| 78103 | Bone marrow imaging; multiple areas (8/1/2018) |
| 78104 | Bone marrow imaging; whole body (8/1/2018) |
| 78140 | Labeled red cell sequestration, differential organ/tissue (eg splenic/hepatic) (8/1/2018) |
| 78185 | Spleen imaging only, with/without vascular flow (8/1/2018) |
| 78195 | Lymphatics and lymph nodes imaging (8/1/2018) |
| 78201 | Liver imaging; static only (8/1/2018) |
| 78202 | Liver imaging with vascular flow (8/1/2018) |
| 78215 | Liver and spleen imaging; static only (8/1/2018) |
| 78216 | Liver and spleen imaging; with vascular flow (8/1/2018) |
| 78226 | Hepatobiliary system imaging, including gallbladder (8/1/2018) |
| 78227 | Hepatobiliary imaging with pharmacologic intervention and quantitative measurement(s) (8/1/2018) |
| 78230 | Salivary gland imaging (8/1/2018) |
| 78231 | Salivary gland imaging with serial images (8/1/2018) |
| 78232 | Salivary gland function study (8/1/2018) |
| 78258 | Esophageal motility (8/1/2018) |
| 78261 | Gastric mucosa imaging (8/1/2018) |
| 78262 | Gastroesophageal reflux study (8/1/2018) |
| 78264 | Gastric emptying imaging study (solid, liquid, or both) (8/1/2018) |
| 78265 | Gastric emptying with small bowel transit (8/1/2018) |
| 78266 | Gastric emptying with small bowel and colon transit, multiple days (8/1/2018) |
| 78300 | Bone and/or joint imaging; limited area (8/1/2018) |
| 78305 | Bone and/or joint imaging; multiple areas (8/1/2018) |
| 78306 | Bone and/or joint imaging; whole body (8/1/2018) |
| 78315 | Bone and/or joint imaging; 3 phase study (8/1/2018) |
| 78430 | Myocardial imaging, PET, perfusion study with CT transmission scan (effective 4/1/2020) |
| 78431 | Myocardial imaging, PET, multiple studies at rest and stress with CT (4/1/2020) |
| 78432 | Myocardial imaging, PET combined perfusion with metabolic evaluation, dual radiotracer (4/1/2020) |
| 78451 | Myocardial perfusion imaging, tomographic (SPECT); single study (9/1/2018) |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies (9/1/2018) |
| 78453 | Myocardial perfusion imaging, planar; single study (9/1/2018) |
| 78454 | Myocardial perfusion imaging, planar; multiple studies (9/1/2018) |
| 78457 | Venous thrombosis imaging, venogram; unilateral (8/1/2018) |
| 78458 | Venous thrombosis imaging, venogram; bilateral (8/1/2018) |
| 78459 | Myocardial imaging, PET, metabolic evaluation single study (9/1/2018) |
| 78491 | Myocardial imaging, PET, perfusion study single study (9/1/2018) |
| 78494 | Myocardial imaging, PET, multiple studies = Cardiac blood pool imaging equivalency (9/1/2018 = 8/1/2018) |
| 78496 | Myocardial imaging, PET, multiple studies = Cardiac blood pool imaging single study (9/1/2018 = 8/1/2018) |
| 78499 | Unlisted cardiovascular procedure, diagnostic nuclear medicine (9/1/2018 = 8/1/2018) |
| 78579 | Myocardial imaging PET perfusion study = Pulmonary ventilation imaging equivalency (9/1/2018 = 8/1/2018) |
| 78580 | Myocardial imaging PET perfusion study = Pulmonary perfusion imaging equivalency (9/1/2018 = 8/1/2018) |
| 78582 | Myocardial imaging PET perfusion study = Pulmonary ventilation and perfusion imaging (9/1/2018 = 8/1/2018) |
| 78597 | Myocardial imaging PET perfusion study = Quantitative differential pulmonary perfusion (9/1/2018 = 8/1/2018) |
| 78598 | Myocardial imaging PET perfusion study = Quantitative differential pulmonary perfusion and ventilation (9/1/2018 = 8/1/2018) |
| 81408 | Molecular pathology Level 8/9 procedures (multi‑exon/multi‑gene analysis) |
| 81410 | Genomic sequence analysis panel for aortic dysfunction/dilation (must include specified genes) |
| 81418 | Drug metabolism (pharmacogenomics) genomic sequence analysis panel (must include CYP2C19, CYP2D6 and duplication/deletion analysis) |
| 81412 | Genomic sequence analysis panel (level 8) — leukodystrophy example; must include sequencing of at least 9 specified genes |
| 81413 | Genomic sequence analysis panel (level 8) — cardiac ion channelopathies; must include sequencing of at least 10 specified genes |
| 81414 | Duplication/deletion gene analysis panel — cardiac ion channelopathies; must include analysis of at least KCNH2 and KCNQ1 |
| 81430 | Hearing loss genomic sequence analysis panel; must include sequencing of at least 60 genes (example gene list) |
| 81439 | Hereditary cardiomyopathy genomic sequence panel; must include sequencing of at least 5 cardiomyopathy-related genes |
| 81503 | mRNA gene expression / algorithmic assays (examples include oncology, coronary artery disease mapping to proprietary assays) |
| 81518 | Breast oncology 11-gene RT-PCR expression profiling (risk/benefit for endocrine therapy) |
| 81595 | Cardiology (heart transplant) 20-gene mRNA profiling for rejection risk score |
| 95905 | Motor and/or sensory nerve conduction, using preconfigured electrode array(s), amplitude and latency/velocity study, each limb, includes F-wave study when performed |
| 95940 | Continuous intraoperative neurophysiology monitoring in the operating room, one on one monitoring requiring personal attendance, each 15 minutes |
| 96130 | Psychological testing evaluation services; first hour |
| 0001U | Red blood cell antigen typing, DNA, human erythrocyte antigen gene analysis of 35 antigens |
| 0007U | Drug test(s), presumptive, with definitive confirmation, urine, includes specimen verification with DNA authentication |
| 0011M | Oncology, prostate cancer, mRNA expression assay of 12 genes, blood plasma and urine |
| 0152U | Infectious disease, microbial cell-free DNA, plasma, untargeted NGS; report for significant positive pathogens |
| 0153U | Oncology (breast), mRNA gene expression profiling by NGS of 101 genes; triple negative breast cancer subtype |
| 0207T | Evacuation of meibomian glands, automated, using heat and intermittent pressure, unilateral |
| 0211U | Oncology (pan-tumor), DNA and RNA by NGS, interpretative report with therapy association |
| 0265U | Genetic test (single nucleotide and copy number variants) — descriptor present |
| 0266U | Whole-transcriptome/NGS for heritable disorders (splicing/expression changes) |
| 0270U | Hematology genomic sequence panels (multiple specific hematology panel mappings) |
| 0290U | Neurology (Alzheimer disease) mRNA gene expression profiling, 24 genes, whole blood, predictive risk score |
| 0306U | Oncology (MRD) NGS patient-specific panel, cell-free DNA, baseline assessment |
| 0335U | Rare diseases whole genome sequence analysis, fetal sample |
| 0340U | Oncology pan-cancer MRD plasma assays personalized to patient |
| 0351U | Infectious disease biochemical assays (TRAIL, IP-10, CRP) algorithm reported as likelihood of bacterial infection |
| 0580T | Removal of substernal implantable defibrillator pulse generator only |
| 0581T | Anatomic model 3D-printed from image data set(s); first individually prepared component |
| 0600T | Ablation, irreversible electroporation; 1 or more tumors per organ, other than liver or prostate, including imaging guidance, percutaneous |
| 0649T | Quantitative magnetic resonance for analysis of tissue composition; single organ (list separately) |
| 0673T | Ablation, benign thyroid nodule(s), percutaneous, laser, including imaging guidance (effective 5/1/2023) |
| 0694T | 3-dimensional volumetric imaging and reconstruction of breast or axillary lymph node tissue, intraoperative |
Provider Submission, Notification and Verification Requirements
Prior authorization required; verify benefits and submit via portal
Prior authorization is required for services and procedures that appear on the current ASO prior authorization list; authorization does not guarantee payment. Verify member benefits and eligibility before providing services and submit electronic preauthorization requests via the secure provider portal (or call the number on the member ID card).
- Prior authorization required for services on the current list; authorization is not a guarantee of payment.
- Verify benefits and eligibility using the member benefit booklet or contact customer service.
- Registered users may submit electronic preauthorization requests via the secure provider portal; call the number on the member ID card or Provider Relations for help.
Notification (not PA) requested for care coordination
For certain services the plan requests notification (not prior authorization) to support discharge planning, care coordination, and case management; these notifications do not replace medical necessity review and are used for operational coordination.
- Notification is requested for some services to assist providers and members with discharge planning, care coordination, and case management.
- All services must still be medically necessary and eligibility/benefit limits apply.
Partial CPT code listing provided for ASO PA/notification
This document includes a partial CPT listing used to identify procedures subject to ASO prior authorization/notification; reference the listed codes when submitting requests.
- Excerpt includes vertebral augmentation, arthrodesis, instrumentation and other spine procedures and continues into shoulder and joint procedures (see code list in policy).
Reference knee arthroscopy / arthroplasty CPT mappings (29867–29871)
Knee arthroscopy and knee arthroplasty/meniscal procedure mappings are listed and must be referenced for ASO processing; examples include 29867, 29868, 29870, and 29871 with effective dates noted.
- 29867 — Arthroscopy, knee, surgical; osteochondral allograft (eg, mosaicplasty).
- 29868 — Arthroplasty, knee, condyle and plateau; medial AND lateral compartments (mapping to meniscal transplantation).
- 29870, 29871 — mappings to diagnostic or infection-related arthroscopy entries; effective 10/1/2018 noted.
Knee and hip arthroscopy code mappings (29874–29889; 29914–29916)
Additional knee and hip arthroscopy CPT mappings are listed and should be used when requesting prior authorization; examples include codes 29874–29889 and hip arthroscopy codes 29914–29916.
- 29874–29889 — multiple knee arthroscopy surgical mappings (synovectomy, meniscectomy, repairs, ACL/PCL procedures) with effective dates 10/1/2018.
- 29914–29916 — hip arthroscopy mappings (femoroplasty, acetabuloplasty, labral repair) with effective dates 10/1/2018.
ENT and airway procedure CPT mappings (rhinoplasty, nasal valve, bronchial thermoplasty)
ENT and airway procedure code mappings (including rhinoplasty, nasal valve repair, and bronchial thermoplasty cross-maps) are included in the ASO listing and must be referenced for authorization requests.
Thoracic and cardiac procedure code mappings (lung transplant, thoracoscopy, cardiac devices)
Thoracic and cardiac procedure mappings (including lung transplant, thoracoscopy, and multiple cardiac device and valve procedure cross-maps) are listed and must be used for ASO prior authorization.
Cardiac and venous procedure CPT mappings (transplant, VAD, TAVR, venous procedures)
Cardiac transplant, VAD, TAVR and venous procedure code mappings are enumerated for authorization reference; providers must reference these codes (examples: 33365–33366, 33927–33983, 34839 and venous mapping codes).
- 33365–33366 — TAVR approach mappings (effective 1/2/2020).
- 33927–33983 — heart transplant, VAD insertion/replacement mappings (effective dates shown).
- 34839 — physician planning of patient-specific fenestrated aortic endograft (effective 1/2/2020 = 4/1/2021).
Venous/vascular procedure CPT mappings (endovenous ablation, ligation/stripping)
Endovenous and vascular procedure mappings (including endovenous ablation, ligation/stripping and related vascular surgery codes) are listed and must be used when submitting prior authorization requests.
- 36465–36483 and 36470–36478 — sclerotherapy and endovenous ablation therapy mappings with effective dates (eg, 36483 effective 3/1/2023).
- 36836–36837 — percutaneous arteriovenous fistula creation mappings (noted 3/1/2023 = 5/1/2023).
- 37700–37799 series — ligation/stripping and unlisted vascular surgery mappings with dates.
Transplant preparation and bariatric procedure code mappings (38206–38241; 43210; 43644–43773)
Transplant preparation and bariatric/gastric procedure code mappings (including HPC preparation and bariatric device/balloon codes) are included and must be referenced for authorization.
- 38206–38214, 38240–38241 — hematopoietic progenitor cell (HPC) transplant preparation and related mappings (effective dates shown).
- 40799 — unlisted transplant-related procedure (effective date shown).
- 43210, 43290–43291, 43644–43773 — EGD with bariatric procedures and gastric restrictive procedure mappings (effective dates noted).
CPT and unlisted procedure mapping excerpt (reference codes and effective dates)
The CPT and unlisted procedure mapping excerpt lists specific CPTs and unlisted mappings used for ASO processing; providers should reference the listed code descriptions and effective dates when requesting authorization.
- Examples include 38240–38241 (HPC prep), 40799 (unlisted), and other mapped CPT entries with effective-date annotations.
Procedural CPT listing (partial) for ASO PA/notification
A partial procedural CPT listing is provided for ASO prior authorization/notification; use the code list in the policy when preparing authorization requests.
- Excerpt includes intrathecal/epidural device implantation codes (62350–62362), decompression and laminectomy codes (62380, 63001–63005) and other procedures with effective dates.
Head/neck CT and MRI CPT codes (70481–70498; 70540–70549)
Head and neck CT and MRI CPT codes (70481–70555 series and 70540–70549) and their contrast/non-contrast permutations are listed with effective dates and must be referenced for imaging authorizations.
Thorax and spine CT/MR codes and crosswalks
Thorax and spine CT/MR code mappings and CTA crosswalks are listed (e.g., 71275, 71550–71555, 72125–72133) and must be used when requesting authorization for thoracic or spinal imaging.
Lower extremity / abdomen / pelvis imaging CPT codes
Lower extremity, abdomen, pelvis and specialized CT/MR codes (e.g., 73700–73725, 74150–74187, 74261–74262) and CT colonography mappings are listed for ASO authorization reference.
- 73700–73725 — lower extremity CT/MR and CTA mappings (effective 8/1/2018).
- 74150–74187 — abdominal and pelvic CT/MR, CT angiography and postprocessing codes (effective 8/1/2018).
- 74261–74262 — CT colonography with image postprocessing (effective 8/1/2018).
Cardiac imaging, CTA and postprocessing codes (75557–75577; 76376–76391)
Cardiac CT/MRI and advanced postprocessing/3D rendering codes are included (e.g., 75557–75577, 75635, 76376–76391); note 75577's mapping date update to 5/1/2026.
- 75557–75563, 75571–75577 — cardiac MRI/CT and CTA codes including 3D postprocessing; 75577 mapping date updated to 5/1/2026.
- 75635, 76376–76377 — CTA abdominal/iliac runoff and 3D rendering/postprocessing descriptors with effective dates.
- 76380–76391, 76497–76498 — additional cardiac CT/MR postprocessing and unlisted imaging procedure codes.
Ancillary imaging and therapeutic radiology CPT codes
Ancillary imaging and therapeutic radiology codes (ultrasound guidance, MRI guidance, breast MRI, bone density, and therapeutic radiology planning/simulation) are listed and must be used for ASO processing.
- 76873, 76979 — ultrasound and contrast characterization entries with effective dates.
- 77021–77049 — MRI guidance and breast MRI codes (effective dates shown).
- 77262–77299, 77300–77338, 77372–77425 — therapeutic radiology planning, simulation, treatment delivery and management codes with 10/1/2021 date notes.
ASO prior authorization/notification listing — Part 7
This section is the ASO Prior Authorization/Notification listing (part 7) and identifies codes subject to ASO prior authorization/notification for self-funded clients; providers must reference the ASO list when initiating requests.
- Part 7 header indicates the codes that follow are within the Self-funded ASO prior authorization/notification catalog.
Procedure and nuclear medicine CPT listings (partial)
Procedure and nuclear medicine code listings (e.g., 78494–78499, 78579–78598 and related series) are provided for ASO consideration and must be referenced for authorization/notification.
- 78494–78499 — myocardial PET perfusion imaging and cardiac blood pool imaging equivalencies (effective 9/1/2018).
- 78579–78598 — PET perfusion equivalency mappings and pulmonary imaging crosswalks (effective dates noted).
- 78430–78432 and other nuclear medicine cardiac imaging codes are included in the listing.
Molecular pathology / genetic test CPT listings (partial)
Molecular pathology and genetic test CPT codes (for example 81161–81351 and the 81408–81430 series) and their panel descriptions and effective dates are enumerated — providers must include the specific CPT when requesting authorization.
Molecular pathology / genomic panels — required gene lists and minimum gene counts
Selected molecular pathology/genomic sequence analysis panels are specified with required gene lists or minimum gene counts (examples include 81410 requiring at least 9 specified genes and 81412 requiring sequencing of at least 9 genes).
- 81410 — aortic dysfunction/dilation panel must include sequencing of at least 9 genes including FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, and MYLK.
- 81412 — Ashkenazi Jewish associated disorders panel must include sequencing of at least 9 genes (ASPA, BLM, CFTR, FANCC, GBA, HEXA, IKBKAP, MCOLN1, SMPD1).
- 81413–81416 — cardiac ion channelopathies and exome/comparator descriptors with minimum gene counts noted.
Expanded genomic panels (81430–81456) — gene-count thresholds and requirements
Expanded genomic panels and duplication/deletion panels (e.g., 81430, 81431, 81439, 81442, 81448–81451, 81455) are listed with required gene-count thresholds or specific gene inclusions and effective dates; reference these entries for authorization.
- 81430 — hearing loss genomic sequence analysis panel example must include sequencing of at least 60 genes (effective dates shown).
- 81439 — hereditary cardiomyopathy panel must include sequencing of at least 5 cardiomyopathy-related genes.
- 81442 — Noonan spectrum disorders panel must include sequencing of at least 12 specified genes.
Gene expression / algorithmic assay CPT codes (examples 81503–81541)
Gene expression and algorithmic assays (CPT codes such as 81503, 81504, 81518, 81519 and others) are enumerated with sample type and algorithm output descriptors; providers must include the specific code when requesting prior authorization.
- 81503 — mRNA gene expression profiling (coronary artery disease mapping to oncology examples), effective 1/1/2023 = 7/1/2025.
- 81518, 81519, 81520–81525 — breast and other oncology expression profiling codes with effective dates and algorithmic output descriptors.
- Providers must reference the exact CPT for algorithmic assays when submitting authorization requests.
Laboratory / immunology / vaccine code listings (selected)
Laboratory, immunology and vaccine CPT/HCPCS codes (e.g., 81560, 81595, 82523, 84999, 86015, 86036–86037, 88267–88269, 90378–90381) are listed with effective dates; use the listed codes in notifications or prior authorization submissions.
Imaging / monitoring / cardiac catheterization CPT codes
Imaging, monitoring and cardiac catheterization codes (e.g., 91110–91113, 92065, 92145, 92548, 92970, 93264, 93451–93461) are enumerated with effective dates and must be used when seeking authorization for related services.
- 93451–93461 — right and left heart catheterization and related combined procedures with effective date notes (11/1/2024 for many entries).
- 93264 — remote monitoring of pulmonary artery pressure sensor for up to 30 days (effective 4/1/2021).
- 91110–91113 — capsule endoscopy and gastrointestinal tract imaging codes with effective dates.
Interventional / congenital catheterization CPT codes (93590–93597)
Interventional and congenital catheterization procedure codes (e.g., 93590–93597 series) are included with effective dates; reference these codes for ASO prior authorization.
- 93590–93592 — percutaneous transcatheter closure of paravalvular leak mappings (effective 1/1/2023 for some entries).
- 93593–93597 — right/left heart catheterization codes for congenital defects with effective dates through 11/1/2024.
Unlisted and miscellaneous CPT/U-code listings (selected)
Unlisted and miscellaneous procedure codes (including unlisted cardiovascular, neurophysiology, psychological testing, home visit, and proprietary genomic assay codes such as 0001U, 0003U, 0005U) are listed with descriptors and effective dates — providers must reference these when applicable.
Use ASO code & test listing when requesting PA/notification
Providers must reference the ASO code and test listing when requesting prior authorization/notification; the listing contains CPT/HCPCS and proprietary codes with descriptors and effective dates used to determine ASO requirements.
- The ASO list is the authoritative code catalog for self-funded prior authorization/notification requirements; providers must reference the specific code(s) when submitting requests.
Code list and descriptors (Part 12) — molecular/genomic and specialized lab services
Part 12 code list enumerates CPT/HCPCS molecular/genomic and specialized laboratory services (0265U–0352T range entries) with descriptors and effective dates; include the exact CPT/U/T code when seeking authorizations.
- 0265U–0268U — genomic and whole-transcriptome test entries with effective dates (eg, 0265U effective 1/1/2022).
- 0266U–0268U — whole-transcriptome and hematology genomic panels described for ASO consideration.
Enumerated T-code and U-code listings (Part 13) for ASO authorization
Part 13 enumerates CPT T-codes and proprietary U-codes with descriptors and effective dates for ASO prior authorization/notification; providers must use these specific codes in requests.
Code listing — authorization reference (selected T- and U-codes)
Specific T- and U-code authorization reference entries (examples: 0478U, 0479T, 0480T, 0481T/0481U, 0483T–0485T/0485U) are listed with descriptors and effective/expiration dates; use the exact code and descriptor when requesting authorization.
- 0478U — Oncology (NSCLC) DNA/RNA digital PCR panel of 9 genes (effective 7/1/2025).
- 0481T/0481U — autologous white blood cell concentrate injection and IDH1/IDH2/TERT NGS descriptors with dates.
- 0483T–0485T series — transcatheter mitral valve implantation and related T-code entries (effective 1/1/2023).
Oncology and advanced diagnostic code entries (selected U-codes)
Additional oncology and novel diagnostic codes (e.g., 0525U spheroid cell culture drug panel, 0530U ctDNA NGS panel) are included for authorization consideration; include the listed code and descriptor when submitting requests.
Category III CPT codes (selection) — reference T-code list
A selection of Category III CPT (T) codes are listed for ASO prior authorization/notification (examples: 0580T–0600T series); providers must reference the specific T-code when applicable.
- 0580T–0600T series — Category III codes including removal of defibrillator pulse generator, anatomic model 3D printing, irreversible electroporation ablation (effective 1/1/2023 for many).
- Sample entries include 0580T (removal of substernal ICD generator) and 0600T (irreversible electroporation ablation).
Category III CPT codes (additional) — T-code examples
Additional Category III CPT (T) codes are listed (0620T–0640T range examples) with effective dates; include the exact T-code when requesting authorization for emerging technologies or procedures.
Category III CPT codes (May 2023 batch) — T-code listings
The May 2023 batch of Category III CPT codes (0673T–0697T and related entries) is enumerated with effective dates (many effective 5/1/2023); providers must reference these T-codes exactly for ASO prior authorization/notification.
- 0673T–0677T and 0683T–0694T — includes ablation, device programming, histotripsy, and 3D imaging/reconstruction codes with effective dates 5/1/2023.
- 0690T–0694T — quantitative ultrasound, automated CT vertebral fracture analysis, therapeutic ultrafiltration and 3D specimen imaging codes (effective 5/1/2023).
Definitions and Terminology
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.